Sunday, November 08th, 2009

Hot Topics : Unique “Payout Method” Instantly Credits Your Bank Account on the 3rd Friday of Every Month

Tug-of-war investing at Under Armour

Mar 24th, 2009 | By Andrew Snyder | Category: Featured, Stock Market Investing

Under Armour (NYSE:UA) is under pressure from both sides. Analysts say it is going down, while emotional investors continue to fall in love. Somebody is going to lose.

Before the opening bell, I was chatting with my colleague, Laura Cadden. I told her of my dire outlook for Under Armour (NYSE:UA) and its overpriced and over-hyped product pipeline.

“You can’t say that,” she rebutted. “I love Under Armour.”

Because she is a Baltimore native – the home of Under Armour – it is easy to understand her affection for the company. But once I gave her a handful of figures and circled a few key spots on the stock’s chart, she tossed her emotions aside and agreed with my call.

That’s when it happened.

Shortly after sharing my opinion, in what I assumed was confidence, the news feed fires up and word hits the Street that Morgan Stanley downgraded Under Armour and cut its price target to just $12. The news comes just 24 hours after Caris made a similar announcement.

It was major blow, especially with shares closing yesterday at $18.73.

Tug-of-war investing

I came into the office this morning planning on recommending a short position on Under Armour to TFN Strategic Trader subscribers, but as soon as I read of today’s downgrade, I knew I was too late.

It would have been a perfect play as share price is down by more than 10%.

Just because I called off my plans for the day does not mean the opportunity is totally lost. Under Armour is a great company for trade-savvy investors. Its shares rise and fall in predictable patterns, creating multiple chances to rack up a hefty profits.

Read the full article here at TFN: Tug-of-war investing at Under Armour


AdvertisementAt Hot Stock Confidential , we've averaged over 32% gains in just 26 trading days

42% on Nymox Pharmaceutical Corp....
23% on Emergent BioSolutions Inc....
38% on the first half of our position in a U.S. refiner...
26.68% on Synta Pharmaceuticals...

How's your favorite financial newsletter working out for you?

Hot Stock Confidential = Damn Good Stocks.

Learn more...

Tags: , ,

By Andrew Snyder

Related Articles



About the Author

Andrew is a contributor to Daily Reckoning Australia and Today's Financial News.

See All Posts by This Author



Today's Financial News provides an independent and practical perspective on the U.S. and global investment markets. We provide you with a free, reliable, easy, up-to-date, and focused resource to help you make your financial decisions with commentary, interviews, recommendations, and video. Today's Financial News includes the analysis and opinions of those editors whom we have come to trust over the course of the years.

See All Posts from This Publication

Leave Comment